Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents

  • Schrag, Anette-Eleonore
  • Martino, Davide
  • Apter, Alan
  • Ball, Juliane
  • Bartolini, Erika
  • Benaroya‑Milshtein, Noa
  • Buttiglione, Maura
  • Cardona, Francesco
  • Creti, Roberta
  • Efstratiou, Androulla
  • Gariup, Maria
  • Georgitsi, Marianthi
  • Hedderly, Tammy
  • Heyman, Isobel
  • Margarit, Immaculada
  • Mir, Pablo
  • Moll, Natalie
  • Morer, Astrid
  • Müller, Norbert
  • Müller-Vahl, Kirsten R.
  • Münchau, Alexander
  • Orefici, Graziella
  • Plessen, Kerstin J.
  • Porcelli, Cesare
  • Paschou, Peristera
  • Rizzo, Renata
  • Roessner, Veit
  • Schwarz, Markus J.
  • Steinberg, Tamar
  • Tagwerker Gloor, Friederike
  • Tarnok, Zsanett
  • Walitza, Susanne
  • Dietrich, Andrea
  • Hoekstra, Pieter J.
EMTICS Collaborative Group., Genetic predisposition, autoimmunity and environmental factors [e.g. pre- and perinatal difficulties, Group A Streptococcal (GAS) and other infections, stress-inducing events] might interact to create a neurobiological vulnerability to the development of tics and associated behaviours. However, the existing evidence for this relies primarily on small prospective or larger retrospective population-based studies, and is therefore still inconclusive. This article describes the design and methodology of the EMTICS study, a longitudinal observational European multicentre study involving 16 clinical centres, with the following objectives: (1) to investigate the association of environmental factors (GAS exposure and psychosocial stress, primarily) with the onset and course of tics and/or obsessive–compulsive symptoms through the prospective observation of at-risk individuals (ONSET cohort: 260 children aged 3–10 years who are tic-free at study entry and have a first-degree relative with a chronic tic disorder) and affected individuals (COURSE cohort: 715 youth aged 3–16 years with a tic disorder); (2) to characterise the immune response to microbial antigens and the host’s immune response regulation in association with onset and exacerbations of tics; (3) to increase knowledge of the human gene pathways influencing the pathogenesis of tic disorders; and (4) to develop prediction models for the risk of onset and exacerbations of tic disorders. The EMTICS study is, to our knowledge, the largest prospective cohort assessment of the contribution of different genetic and environmental factors to the risk of developing tics in putatively predisposed individuals and to the risk of exacerbating tics in young individuals with chronic tic disorders., This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under Grant agreement no. 278367. Schrag was supported by the National Institute for Health Research UCLH Biomedical Research Centre, and Müller, Burger, Schnell and Weidinger by Stiftung Immunität und Seele. This research was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (Heyman); partially sponsored by GSK Vaccines (Margarit, Bartolini); and Deutsche Forschungsgemeinschaft (DFG): projects 1692/3-1, 4-1 (Münchau)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study

  • Schrag, Anette-Eleonore
  • Martino, Davide
  • Wang, Hanyuying
  • Ambler, Gareth
  • Benaroya-Milstein, Noa
  • Buttiglione, Maura
  • Cardona, Francesco
  • Creti, Roberta
  • Efstratiou, Androulla
  • Hedderly, Tammy
  • Heyman, Isobel
  • Huyser, Chaim
  • Mir, Pablo
  • Morer, Astrid
  • Moll, Natalie
  • Müller, Norbert
  • Müller-Vahl, Kirsten R.
  • Plessen, Kerstin J.
  • Porcelli, Cesare
  • Rizzo, Renata
  • Roessner, Veit
  • Schwarz, Markus
  • Tarnok, Zsanett
  • Walitza, Susanne
  • Dietrich, Andrea
  • Hoekstra, Pieter J.
[Background and Objectives] The goal of this work was to investigate the association between group A streptococcal (GAS) infections and tic incidence among unaffected children with a family history of chronic tic disorders (CTDs)., [Methods] In a prospective cohort study, children with no history for tics who were 3 to 10 years of age with a first-degree relative with a CTD were recruited from the European Multicentre Tics in Children Study (EMTICS) across 16 European centers. Presence of GAS infection was assessed with throat swabs, serum anti–streptolysin O titers, and anti-DNAse titers blinded to clinical status. GAS exposure was defined with 4 different definitions based on these parameters. Cox regression analyses with time-varying GAS exposure were conducted to examine the association of onset of tics and GAS exposure during follow-up. Sensitivity analyses were conducted with Cox regression and logistic regression analyses., [Results] A total of 259 children were recruited; 1 child was found to have tic onset before study entry and therefore was excluded. Sixty-one children (23.6%) developed tics over an average follow-up period of 1 (SD 0.7) year. There was a strong association of sex and onset of tics, with girls having an ≈60% lower risk of developing tics compared to boys (hazard ratio [HR] 0.4, 95% confidence interval [CI] 0.2–0.7). However, there was no statistical evidence to suggest an association of any of the 4 GAS exposure definitions with tic onset (GAS exposure definition 1: HR 0.310, 95% CI 0.037–2.590; definition 2: HR 0.561, 95% CI 0.219–1.436; definition 3: HR 0.853, 95% CI 0.466–1.561; definition 4: HR 0.725, 95% CI 0.384–1.370)., [Discussion] These results do not suggest an association between GAS exposure and development of tics., This project has received funding from the European Union’s Seventh Framework Program for research and technological development under grant agreement No. 278367., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Association of Group A Streptococcus Exposure and Exacerbations of Chronic Tic Disorders: A Multinational Prospective Cohort Study

  • Martino, Davide
  • Schrag, Anette
  • Anastasiou, Zacharias
  • Apter, Alan
  • Benaroya-Milstein, Noa
  • Buttiglione, Maura
  • Cardona, Francesco
  • Creti, Roberta
  • Efstratiou, Androulla
  • Hedderly, Tammy
  • Heyman, Isobel
  • Huyser, Chaim
  • Madruga, Marcos
  • Mir, Pablo
  • Morer, Astrid
  • Mol Debes, Nanette
  • Moll, Natalie
  • Müller, Norbert
  • Müller-Vahl, Kirsten
  • Munchau, Alexander
  • Nagy, Peter
  • Plessen, Kerstin Jessica
  • Porcelli, Cesare
  • Rizzo, Renata
  • Roessner, Veit
  • Schnell, Jaana
  • Schwarz, Markus
  • Skov, Liselotte
  • Steinberg, Tamar
  • Tarnok, Zsanett
  • Walitza, Susanne
  • Dietrich, Andrea
  • Hoekstra, Pieter J.
Objective To examine prospectively the association between group A Streptococcus (GAS) pharyngeal exposures and exacerbations of tics in a large multicenter population of youth with chronic tic disorders (CTD) across Europe. Methods We followed up 715 children with CTD (age 10.7 ± 2.8 years, 76.8% boys), recruited by 16 specialist clinics from 9 countries, and followed up for 16 months on average. Tic, obsessive-compulsive symptom (OCS), and attention-deficit/hyperactivity disorder (ADHD) severity was assessed during 4-monthly study visits and telephone interviews. GAS exposures were analyzed using 4 possible combinations of measures based on pharyngeal swab and serologic testing. The associations between GAS exposures and tic exacerbations or changes of tic, OC, and ADHD symptom severity were measured, respectively, using multivariate logistic regression plus multiple failure time analyses and mixed effects linear regression. Results A total of 405 exacerbations occurred in 308 of 715 (43%) participants. The proportion of exacerbations temporally associated with GAS exposure ranged from 5.5% to 12.9%, depending on GAS exposure definition. We did not detect any significant association of any of the 4 GAS exposure definitions with tic exacerbations (odds ratios ranging between 1.006 and 1.235, all p values >0.3). GAS exposures were associated with longitudinal changes of hyperactivity–impulsivity symptom severity ranging from 17% to 21%, depending on GAS exposure definition. Conclusions This study does not support GAS exposures as contributing factors for tic exacerbations in children with CTD. Specific workup or active management of GAS infections is unlikely to help modify the course of tics in CTD and is therefore not recommended., This project has received funding from the European Union’s Seventh Framework Program for research, technological development and demonstration under grant agreement 278367., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome-Wide Association Study Points to Novel Locus for Gilles de la Tourette Syndrome

  • Tsetsos, Fotis
  • Topaloudi, Apostolia
  • Jain, Pritesh
  • Yang, Zhiyu
  • Yu, Dongmei
  • Kolovos, Petros
  • Tumer, Zeynep
  • Rizzo, Renata
  • Hartmann, Andreas
  • Depienne, Christel
  • Worbe, Yulia
  • Müller-Vahl, Kirsten R.
  • Cath, Danielle C.
  • Boomsma, Dorret I.
  • Wolanczyk, Tomasz
  • Zekanowski, Cezary
  • Barta, Csaba
  • Nemoda, Zsofia
  • Tarnok, Zsanett
  • Padmanabhuni, Shanmukha S.
  • Buxbaum, Joseph D.
  • Grice, Dorothy
  • Glennon, Jeffrey
  • Stefansson, Hreinn
  • Hengerer, Bastian
  • Yannaki, Evangelia
  • Stamatoyannopoulos, John A.
  • Benaroya-Milshtein, Noa
  • Cardona, Francesco
  • Hedderly, Tammy
  • Heyman, Isobel
  • Huyser, Chaim
  • Mir, Pablo
  • Morer, Astrid
  • Mueller, Norbert
  • Munchau, Alexander
  • Plessen, Kerstin J.
  • Porcelli, Cesare
  • Roessner, Veit
  • Walitza, Susanne
  • Schrag, Anette
  • Martino, Davide
  • Tischfield, Jay A.
  • Heiman, Gary A.
  • Willsey, A Jeremy
  • Dietrich, Andrea
  • Davis, Lea K.
  • Crowley, James J.
  • Mathews, Carol A.
  • Scharf, Jeremiah M.
  • Georgitsi, Marianthi
  • Hoekstra, Pieter J.
  • Paschou, Peristera
[Background] Tourette syndrome (TS) is a childhood-onset neurodevelopmental disorder of complex genetic architecture and is characterized by multiple motor tics and at least one vocal tic persisting for more than 1 year., [Methods] We performed a genome-wide meta-analysis integrating a novel TS cohort with previously published data, resulting in a sample size of 6133 individuals with TS and 13,565 ancestry-matched control participants., [Results] We identified a genome-wide significant locus on chromosome 5q15. Integration of expression quantitative trait locus, Hi-C (high-throughput chromosome conformation capture), and genome-wide association study data implicated the NR2F1 gene and associated long noncoding RNAs within the 5q15 locus. Heritability partitioning identified statistically significant enrichment in brain tissue histone marks, while polygenic risk scoring of brain volume data identified statistically significant associations with right and left thalamus volumes and right putamen volume., [Conclusions] Our work presents novel insights into the neurobiology of TS, thereby opening up new directions for future studies., This work was supported by EMTICS (FP7-HEALTH, Grant agreement ID No. 278367 [to PP and PJH]), TS-EUROTRAIN (FP7-PEOPLE, Grant agreement ID No. 316978 [to PP]), the National Institute of Neurological Disorders and Stroke (Grant No. R01NS105746), U.S. National Science Foundation (Grant Nos. 2006929 and 1715202 [to PP]), and the National Institute of Mental Health (Grant No. R01MH126213 [to PP]). AJW also received funding from the National Institute of Neurological Disorders and Stroke Grant No. R01NS105746, the Tourette Association of America, and the Weill Institute for Neurosciences. AM received funding from the Deutsche Forschungsgemeinschaft (Grant No. FOR 2698). AS received support from the NIHR UCL/H Biomedical Research Centre. BH is an employee of Boehringer Ingelheim Pharma. CJ received funding from Lundbeck Fonden (Grant No. R100-2011-9332). CB received funding from the Merit-prize fellowship of Semmelweis University, the Bolyai Janos research fellowship of the Hungarian Academy of Sciences (Grant No.BO/00987/16/5), the UNKP-18-4 of the new National Excellence Program of the Ministry of Human Capacities, and the Baron Munchausen Program of the Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University. DCC received funding from the TSAA, the Stichting VC-GGZ, and TS-EUROTRAIN. DM has received research support from Ipsen Corporate and funding grants from Dystonia Medical Research Foundation Canada, Parkinson Canada, The Owerko Foundation, and the Michael P. Smith Family. LKD was supported by grants from the National Institutes of Health (Grant Nos. R01NS102371 and R01NS105746). PM has received grants from the Spanish Ministry of Science and Innovation (Grant No. RTC2019-007150-1), the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Grant Nos. PI16/01575, PI19/01576), the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia (Grant Nos. CVI-02526, CTS-7685), and the Consejeria de Salud y Bienestar Social de la Junta de Andalucia, (Grant No. PE-0210-2018). PJ and CZ were funded by the National Science Center, Poland (Grant No. UMO-2016/23/B/NZ2/03030). ZT was funded by Lundbeck Fonden (Grant No. R100-2011-9332). TIC Genetics (Tourette International Collaborative Genetics) was supported by the National Institutes of Health (Grant Nos. MH115958, MH115960, MH115962, MH115961, MH115993, MH115963, and MH115959) and the New Jersey Center for Tourette Syndrome and Associated Disorder., Peer reviewed